Publications
361
Citations
8,645
Est. group size
—
Recurring co-author estimate
Active years
23
Publishing since 2004
Marwan Ghabril studies diseases of the liver, focusing especially on drug-induced liver injury (harm to the liver caused by medications, herbal products, and dietary supplements) and on liver transplantation. The work combines clinical studies, genetic associations (such as how immune-system HLA genes relate to certain drug reactions), and quality-of-care evaluations to better understand and manage liver conditions.
Publication output rose through the late 2010s, peaked around 2020, and has remained steady at roughly 25 papers per year in recent years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- 635 HEPATIC SAFETY SIGNALS IN U.S. FOOD AND DRUG ADMINISTRATION (FDA) COMPLETE RESPONSE LETTERS: A SYSTEMATIC EVALUATION BASED ON THE OPENFDA CRL TABLE
Gastrointestinal Endoscopy · 2026
- 635 HEPATIC SAFETY SIGNALS IN U.S. FOOD AND DRUG ADMINISTRATION (FDA) COMPLETE RESPONSE LETTERS: A SYSTEMATIC EVALUATION BASED ON THE OPENFDA CRL TABLE
Gastroenterology · 2026
- Clinical and HLA Associations of Fluoroquinolone-Induced Liver Injury: Results From the Drug-Induced Liver Injury Network
The American Journal of Gastroenterology · 2025
- AASLD AST Practice Guideline on adult liver transplantation: Diagnosis and post-transplant management of non-graft–related complications
Liver Transplantation · 2025
- Association Between Older Age and TIPS‐Related Hospitalization Following Shunt Placement
Canadian Journal of Gastroenterology and Hepatology · 2025
- Exploring Patient and Provider Narratives: A Qualitative Study Identifying Barriers in Liver Transplantation Referral
BMC Health Services Research · 2025
- Sa1535: GLP1 RECEPTOR AGONISTS AND HEPATIC DECOMPENSATION IN PATIENTS WITH MASH CIRRHOSIS: A PROPENSITY-MATCHED ANALYSIS OF THE US COLLABORATIVE NETWORK
Gastroenterology · 2025
- FRI-153 Prognostic significance of very high and towering peak alanine aminotransferase (ALT) values with normal or near normal total bilirubin in patients with idiosyncratic drug-induced liver injury
Journal of Hepatology · 2025
- Drug‐Induced Liver Injury in Patients With Chronic Liver Disease
Liver International · 2025
- Incidence of Possible Drug-induced Liver Injury Due to Commonly Implicated Agents in the United States
Clinical Gastroenterology and Hepatology · 2024
- <scp>Drug‐induced</scp> liver injury (<scp>DILI</scp>) ascribed to non‐steroidal anti‐inflammatory drugs (<scp>NSAIDs</scp>) in the <scp>USA</scp>—Update with genetic correlations
Liver International · 2024
- Management of coagulopathy among patients with cirrhosis undergoing upper endoscopy and paracentesis: Persistent gaps and areas of consensus in a multispecialty Delphi
Hepatology · 2024
- Quality measures in pre-liver transplant care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases
Hepatology · 2024
- Drug-induced Liver Injury Due to Medications for Alcohol Use Disorder: Results From the DILIN Prospective Study
Journal of Addiction Medicine · 2024
- Clinical characteristics and <scp>HLA</scp> associations of azithromycin‐induced liver injury
Alimentary Pharmacology & Therapeutics · 2024
- Gastroenterology×40
- The American Journal of Gastroenterology×24
- PMC×14
- Journal of Hepatology×11
- Clinical Gastroenterology and Hepatology×11
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile